Clotilde Aubertin is Director of External Innovation at Haleon, where she leads global open‑innovation and partnership strategies across consumer health and OTC categories. With a multidisciplinary background spanning biology, nutrition, pharmacy, and a PhD in Informationa and communication sciences (big data), she has built a career at the intersection of advanced science, data, and real‑world impact. Over the past two decades, Clotilde has driven innovation across academia, public research institutions, and global industry, including close collaboration with INSERM, Nestlé, GSK, and Haleon. Her work focuses on translating emerging science into scalable solutions, with particular expertise in pain management, inflammation, respiratory health, microbiome and mucosal health, advanced delivery systems, and AI‑driven innovation. Deeply engaged in the Swiss and European biotech ecosystems, she is an active mentor, board‑certified advisor, and contributor to innovation hubs and health‑tech initiatives. At BioTechX, she brings a pragmatic perspective on how cutting‑edge research, data, and partnerships can be transformed into meaningful value for patients and consumers.